- Business Wire•2 hours ago
Pfizer Inc. today announced the successful completion of its acquisition of Medivation, Inc. . As of the tender offer expiration, 115,574,041 shares of Medivation common stock were validly tendered, representing approximately 69.1% of the shares outstanding and have been accepted for payment under the terms of the tender offer for $81.50 per share in cash, without interest, subject to any required ...
- Marketwired•5 hours ago
Medivation, Inc. today announced that new data from Company-sponsored and investigator-initiated clinical trials will be presented at the European Society for Medical Oncology 2016 Congress, being held ...
- Investor's Business Daily•2 days ago
Pfizer ended years of speculation that it would split into separate businesses, one focused on new drugs and the other on off-patent drugs.
Medivation, Inc. (MDVN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||81.40 x 1000|
|Ask||81.49 x 5200|
|Day's Range||81.43 - 81.48|
|52wk Range||26.41 - 81.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-75.34|
|Avg Vol (3m)||4,292,837|
|Dividend & Yield||N/A (N/A)|